4//SEC Filing
Piekos Brian 4
Accession 0000899243-21-040808
CIK 0001816736other
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 5:49 PM ET
Size
5.8 KB
Accession
0000899243-21-040808
Insider Transaction Report
Form 4
Piekos Brian
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2021-10-18+90,720→ 90,720 total→ Common Stock (90,720 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the right to receive one share of Gemini Therapeutics, Inc. common stock.
- [F2]Thirty-three percent (33%) of the Restricted Stock Units shall vest upon the achievement of a clinical milestone, and the remaining sixty-seven percent (67%) of the Restricted Stock Units shall vest on the one (1)-year anniversary of the achievement of this clinical milestone.
Documents
Issuer
Gemini Therapeutics, Inc. /DE
CIK 0001816736
Entity typeother
Related Parties
1- filerCIK 0001815308
Filing Metadata
- Form type
- 4
- Filed
- Oct 19, 8:00 PM ET
- Accepted
- Oct 20, 5:49 PM ET
- Size
- 5.8 KB